Anti-babesial compounds from Curcuma xanthorrhiza

Area of Science:

• Natural Product Chemistry
• Parasitology
• Medicinal Chemistry

Background:

• Babesiosis is a tick-borne parasitic disease impacting livestock and humans.
• Curcuma xanthorrhiza is a traditional medicinal plant with potential therapeutic properties.
• Existing treatments for babesiosis can have limitations, necessitating the search for novel agents.

Purpose of the Study:

• To isolate and characterize anti-babesial compounds from Curcuma xanthorrhiza.
• To revise the structural assignment of known compounds and isolate new ones.
• To evaluate the in vitro efficacy of isolated compounds against Babesia parasites.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation utilizing extensive Nuclear Magnetic Resonance (NMR) spectroscopy.
• In vitro anti-babesial activity assay to determine IC(50) values.

Main Results:

• Two anti-babesial ingredients, (12R)- and (12S)-12,13-dihydro-12,13-dihydroxyxanthorrhizols, were successfully isolated from Curcuma xanthorrhiza.
• The (1)H NMR data assignment for (12R)-12,13-dihydro-12,13-dihydroxyxanthorrhizol was revised.
• (12S)-12,13-dihydro-12,13-dihydroxyxanthorrhizol was isolated in pure form for the first time, with IC(50) values of 8.3 and 11.6 μg/mL, respectively, compared to Ganaseg's 0.6 μg/mL.

Conclusions:

• Curcuma xanthorrhiza contains compounds with significant anti-babesial activity.
• The isolated dihydroxyxanthorrhizols show promise as potential therapeutic agents for babesiosis.
• Further research is warranted to explore the in vivo efficacy and mechanism of action of these natural compounds.